Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Penumbra, Inc. before investing.

In this article, we go over a few key elements for understanding Penumbra, Inc.’s stock price such as:

• Penumbra, Inc.’s current stock price and volume
• Why Penumbra, Inc.’s stock price changed recently
• Upgrades and downgrades for PEN from analysts
• PEN’s stock price momentum as measured by its relative strength

About Penumbra, Inc. (PEN)

Before we jump into Penumbra, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

Want to learn more about Penumbra, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Penumbra, Inc..

Penumbra, Inc.’s Stock Price as of Market Close

As of July 31, 2026, 4:00 PM, CST, Penumbra, Inc.’s stock price was $321.190.

Penumbra, Inc. is up 0.43% from its previous closing price of $319.830.

During the last market session, Penumbra, Inc.’s stock traded between $318.700 and $323.050. Currently, there are approximately 39.35 million shares outstanding for Penumbra, Inc..

Penumbra, Inc.’s price-earnings (P/E) ratio is currently at 79.0, which is high compared to the Health Care Equipment & Supplies industry median of 31.1. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Penumbra, Inc. Stock Price History

Penumbra, Inc.’s (PEN) price is currently up 1.72% so far this month.

During the month of July, Penumbra, Inc.’s stock price has reached a high of $323.050 and a low of $314.985.

Over the last year, Penumbra, Inc. has hit prices as high as $362.410 and as low as $221.260. Year to date, Penumbra, Inc.’s stock is up 3.31%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Penumbra, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of July 31, 2026, there were 0 analysts who downgraded Penumbra, Inc.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Penumbra, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Penumbra, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Penumbra, Inc.’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Penumbra, Inc. (PEN) by visiting AAII Stock Evaluator.

Relative Price Strength of Penumbra, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of July 31, 2026, Penumbra, Inc. has a weighted four-quarter relative price strength of 3.06%, which translates to a Momentum Score of 64 and is considered to be Strong.

Want to learn more about how Penumbra, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Penumbra, Inc. Stock Price: Bottom Line

As of July 31, 2026, Penumbra, Inc.’s stock price is $321.190, which is up 0.43% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Penumbra, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.